Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Fludarabine + Rituximab in Indolent Lymphoma
NCT00311129Phase 2Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine in lymphoma, sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
fludarabine
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00311129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311129.